PharMerica (PMC) Tops Q3 EPS by 17c; Guides Higher

November 5, 2013 8:10 AM EST Send to a Friend
PharMerica (NYSE: PMC) reported Q3 EPS of $0.49, $0.17 better than the analyst estimate of $0.32. Revenue ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login